Page last updated: 2024-09-04

glucagon and miglitol

glucagon has been researched along with miglitol in 4 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(miglitol)
Trials
(miglitol)
Recent Studies (post-2010) (miglitol)
26,0391,4983,05426988115

Protein Interaction Comparison

ProteinTaxonomyglucagon (IC50)miglitol (IC50)
Maltase-glucoamylase, intestinalHomo sapiens (human)4.4667
Lysosomal alpha-glucosidaseHomo sapiens (human)1.1167
Sucrase-isomaltase, intestinalHomo sapiens (human)0.5
Sucrase-isomaltase, intestinalRattus norvegicus (Norway rat)1.3343
Glycogen debranching enzymeOryctolagus cuniculus (rabbit)0.39
Lysosomal alpha-glucosidaseRattus norvegicus (Norway rat)1.1225

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bollen, M; Stalmans, W; Vandebroeck, A1
Horowitz, M; Lee, A; Morley, JE; Patrick, P; Wishart, J1
Aoki, K; Kamiyama, H; Masuda, K; Shibuya, M; Terauchi, Y; Yoshimura, K1
Kishimoto, M; Noda, M1

Trials

2 trial(s) available for glucagon and miglitol

ArticleYear
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
    Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:5

    Topics: 1-Deoxynojirimycin; Adult; Aged; Appetite; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Protein Precursors

2002
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
    Acta diabetologica, 2012, Volume: 49, Issue:3

    Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Food-Drug Interactions; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles

2012

Other Studies

2 other study(ies) available for glucagon and miglitol

ArticleYear
1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a.
    Biochemical pharmacology, 1988, Mar-01, Volume: 37, Issue:5

    Topics: 1-Deoxynojirimycin; Animals; Dose-Response Relationship, Drug; Glucagon; Glucosamine; Glycogen Synthase; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Liver; Liver Glycogen; Male; Phosphorylase a; Phosphorylases; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1988
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
    Cardiovascular diabetology, 2011, Dec-22, Volume: 10

    Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles

2011